Mustang Bio
MBIO
11 hedge funds and large institutions have $9.18M invested in Mustang Bio in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
1,711% more capital invested
Capital invested by funds: $507K → $9.18M (+$8.67M)
1,000% more funds holding
Funds holding: 1 → 11 (+10)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.82M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$549K |
| 3 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$325K |
| 4 |
Millennium Management
New York
|
+$279K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$162K |
Top Sellers
MBIO Hedge Fund Activity: Q4 2017 in Review
11 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2017, worth a combined $9.18M — up 1,711% from $507K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MBIO positions and 0 closed out — a net gain of 10 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $5.82M.
- 11 institutional investors held Mustang Bio (MBIO) as of Q4 2017, up from 1 in Q3 2017.
- Funds reported $9.18M of Mustang Bio stock for Q4 2017, up 1,711% quarter-over-quarter.
- 10 funds opened new Mustang Bio positions in Q4 2017 and 0 closed out, a net change of +10 holders.
- The largest Mustang Bio buyer in Q4 2017 was Vanguard Group, an estimated $5.82M added.
Based on aggregated 13F filings for Q4 2017.